AzTrials
AzTrials

Metabolic SyndromNCT06509464

Response Of Metabolic Syndrome Severity Score To High Intenisty Interval Training In Women With Central Obesity.

A study testing High intensity interval training and Caloric restricted diet in people with Metabolic Syndrom, run by Soma Adel Gaber Abd El-Ghany at 1 site in Egypt.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

This study will be conducted to investigate any significant effect of high intensity interval training on metabolic syndrome severity score in women with central obesity. Read more about this study

Who is it for?
Ages 25 to 45 years, women only
Conditions the study is for
Metabolic Syndrom
What is being tested?
High intensity interval training and Caloric restricted diet
Type of treatment
Medical device
Could I receive a placebo?
No, everyone receives an active treatment
How many people
48 participants
Where
1 siteEgypt
Study dates
20 Dec 2024to 15 Jun 2025
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 25 to 45 years
  • Women only
  • No healthy volunteers
  • Adult

Who may be able to join

  • 1. 48 Women subjects with age ranges from 25to 45 years.
  • 2. Waist height ratio ranges from 49-58 (overweight and seriously overweight).

Who cannot join

  • 1. Uncontrolled Diabetes 2. Uncontrolled hypertension 3. Cognitive impaired patients 4. Severe Anemic women 5. Subjects with physical or musculoskeletal disabilities 6. Pregnancy 7. Recent cardiothoracic surgery

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Soma Adel Abd El-Ghany, Master degree contact

0106 196 2553 ext. 002

Somaadelxp123@gmail.com

Hanan Mohamed, Bsc contact

01151312322 ext. 02

eth.com@pt.cu.edu.eg

Egypt1 site, 1 recruiting
  • Faculty of physical therapy cairo university

    Giza, 12611

    Hanan Mohamed, BSc, 01151312322 ext. 002, eth.com@pt.cu.edu.eg

    Recruiting

Other trials in Egypt

About this study

This study will be conducted to investigate any significant effect of high intensity interval training on metabolic syndrome severity score in women with central obesity.

Read the detailed description

RESPONSE OF METABOLIC SYNDROME SEVERITY SCORE TO HIGH INTENISTY INTERVAL TRAINING IN WOMEN WITH CENTRAL OBESITY

forty eight women with age ranges from 25 to 45 years old will be selected from nutrition-outpatient clinic; they will participate in the study for 6 weeks, and randomly be assigned into two equal groups.

Study group A (n =24) will receive low volume High-intensity interval training (HIIT) three times /week for 6 weeks , study group B (n =24) will receive caloric restriction diet

For evaluation Physical efficiency index using Modified Harvard Step test It is a powerful indicator for aerobic fitness. The Fitness Index score is determined according to the following equation

Fitness Index (long form) = (100 x test duration in seconds) divided by (2 x sum of heart beats in the recovery periods).

Metabolic syndrome severity score Metabolic syndrome severity score will be calculated through MetS Calculator (MetSCalc).

-3Laboratory investigation before \& after treatment: for fasting blood glucose level and Lipid profile (total cholesterol, LDL, HDL, TAGs).

4- The 45-item Diet Satisfaction Questionnaire (DSat-45)

  1. For treatment

1- Grand II Treadmill: (AC999- for maximum weight 150 Kg-

Being tested
High intensity interval training, Caloric restricted diet
Keywords
Metabolic syndrom severity score, Metabolic syndrom, Central obesity
Medical subject headings
Obesity, Abdominal

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • High intensity interval trainingDevice

    High intensity interval training on treadmill

  • Caloric restricted dietDietary supplement

    Caloric restricted diet

Study groups in NCT06509464
Study groupRoleWhat they receive
low volume High-intensity interval training (HIIT)Experimentalgroup A (n =24) will receive low volume High-intensity interval training (HIIT) three times /week for 3 months,
Receives: Device: High intensity interval training; Dietary Supplement: Caloric restricted diet
caloric restricted diet.Experimentalgroup B (24) will receive caloric restricted diet.
Receives: Device: High intensity interval training; Dietary Supplement: Caloric restricted diet

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Metabolic syndrome severity score

    Measured: 6weeks

  2. Physical efficiency index using Modified Harvard Step test

    Measured: 6weeks

  3. The 45-item Diet Satisfaction Questionnaire (DSat-45

    Measured: 6 weeks

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted19 Jul 2024
  2. Study start20 Dec 2024
  3. Primary completion30 May 2025 (estimated)
  4. Study completion15 Jun 2025 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Participant
Enrolment
48 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06509464
Sponsor's protocol ID
Cairo soma 46
Status last verified
Apr 2025
First submitted
9 Jul 2024
Last updated
9 Apr 2025
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

A study testing High intensity interval training and Caloric restricted diet in people with Metabolic Syndrom, run by Soma Adel Gaber Abd El-Ghany at 1 site in Egypt.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 9 Apr 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Egypt. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Soma Adel Abd El-Ghany, Master degree (0106 196 2553 ext. 002, Somaadelxp123@gmail.com), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Metabolic syndrome severity score (time frame: 6weeks). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 9 Apr 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in